This pattern is well supported by evidence from the SURMOUNT clinical trial programme, which consistently demonstrated that gastrointestinal adverse events decreased in frequency as participants progressed through treatment
In the LEAD-6 trial, overall adverse events were lower with the liraglutide group, compared with exenatide twice daily (74.9% versus 78.9%, respectively) but the severity of these effects where higher with liraglutide (serious AEs 5.1%, severe AEs 7.2%) than exenatide twice daily (serious AEs 2.6%, severe AEs 4.7%) [Buse et al
Improve Sleep (Even If Its Not Perfect) Sleep deprivation lowers GLP-1 and increases hunger hormones like ghrelin
With the Lipo B Shots, you get a variety of different types of vitamin B, including certain types that can be more difficult to get in your diet alone
A 2020 study found that, compared to a placebo, people taking B